Biogen制药

$Biogen制药(BIIB)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0001193125-26-134910  Size: 4 MB 网页链接

$Biogen制药(BIIB)$ SC TO-C Written communication relating to an issuer or third party Accession Number: 0000950157-26-000452  Size: 149 KB 网页链接

$Biogen制药(BIIB)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001193125-26-134889  Act: 34  Size: 5 MB 网页链接

$Biogen制药(BIIB)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000102909-26-000745  Act: 34  Size: 7 KB 网页链接

$Biogen制药(BIIB)$ 8-K Current report, item 5.02 Accession Number: 0000950157-26-000280  Act: 34  Size: 155 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000032  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000033  Size: 6 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000034  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000035  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000027  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000026  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000028  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000030  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000029  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000031  Size: 5 KB 网页链接

$Biogen制药(BIIB)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0001193125-26-046803  Act: 34  Size: 131 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000023  Size: 14 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000024  Size: 13 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000015  Size: 19 KB 网页链接

$Biogen制药(BIIB)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000875045-26-000016  Size: 18 KB 网页链接